BlackRock, Inc. 13D and 13G filings for AVEO Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-09 6:02 pm Purchase | 2021-03-31 | 13G | AVEO Pharmaceuticals, Inc. AVEO | BlackRock Inc. BLK | 1,605,160 4.800% | 36,805 (+2.35%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | AVEO Pharmaceuticals, Inc. AVEO | BlackRock Inc. BLK | 1,568,355 5.400% | 1,568,355 (New Position) | Filing |